CY1112738T1 - Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη - Google Patents

Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη

Info

Publication number
CY1112738T1
CY1112738T1 CY20121100406T CY121100406T CY1112738T1 CY 1112738 T1 CY1112738 T1 CY 1112738T1 CY 20121100406 T CY20121100406 T CY 20121100406T CY 121100406 T CY121100406 T CY 121100406T CY 1112738 T1 CY1112738 T1 CY 1112738T1
Authority
CY
Cyprus
Prior art keywords
paracetamol
composition containing
combined composition
containing ibuprofen
ibuprofen
Prior art date
Application number
CY20121100406T
Other languages
Greek (el)
English (en)
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aft Pharmaceuticals Limited filed Critical Aft Pharmaceuticals Limited
Publication of CY1112738T1 publication Critical patent/CY1112738T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
CY20121100406T 2004-07-07 2012-04-30 Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη CY1112738T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ53398204 2004-07-07
EP05764510A EP1781277B1 (en) 2004-07-07 2005-07-07 A combination composition comprising ibuprofen and paracetamol

Publications (1)

Publication Number Publication Date
CY1112738T1 true CY1112738T1 (el) 2016-02-10

Family

ID=35783254

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20121100406T CY1112738T1 (el) 2004-07-07 2012-04-30 Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
CY2023026C CY2023026I2 (el) 2004-07-07 2023-12-19 Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY2023026C CY2023026I2 (el) 2004-07-07 2023-12-19 Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη

Country Status (21)

Country Link
US (4) US20080275125A1 (enExample)
EP (1) EP1781277B1 (enExample)
JP (1) JP5630943B2 (enExample)
KR (1) KR101370712B1 (enExample)
CN (1) CN101022789A (enExample)
AT (1) ATE543491T1 (enExample)
AU (2) AU2005260243B2 (enExample)
BR (1) BRPI0512756A (enExample)
CA (1) CA2570474C (enExample)
CY (2) CY1112738T1 (enExample)
DK (1) DK1781277T3 (enExample)
ES (1) ES2381794T3 (enExample)
GB (1) GB2431346C (enExample)
LT (1) LTC1781277I2 (enExample)
MX (1) MX2007000117A (enExample)
PL (1) PL1781277T3 (enExample)
PT (1) PT1781277E (enExample)
RU (2) RU2007101686A (enExample)
SI (1) SI1781277T1 (enExample)
WO (1) WO2006004449A2 (enExample)
ZA (1) ZA200700896B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5630943B2 (ja) 2004-07-07 2014-11-26 エイ・エフ・ティ・ファーマスーティカルズ・リミテッドＡｆｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｉｍｉｔｅｄ 複合剤組成物
ZA200803566B (en) * 2005-12-12 2009-10-28 Adcock Ingram Ltd Pharmaceutical compositions
CN101563074B (zh) 2006-10-20 2012-11-07 麦克内尔-Ppc股份有限公司 乙酰氨基酚/布洛芬组合
JP5676834B2 (ja) * 2006-11-29 2015-02-25 エスエス製薬株式会社 消化管への刺激性を減少した経口固形組成物
WO2009012590A1 (en) * 2007-07-23 2009-01-29 Kingsway Pharmaceuticals Inc. Therapeutic formulations for the treatment of cold and flu-like symptoms
WO2009083759A1 (en) * 2008-01-03 2009-07-09 Wockhardt Research Centre Oral pharmaceutical suspension comprising paracetamol and ibuprofen
KR20110112279A (ko) * 2008-10-14 2011-10-12 에이에프티 파마슈티칼스 리미티드 의약품 및 치료
DE102010008876B4 (de) 2010-02-22 2017-07-27 Integrated Micro-Electronics Bulgaria Lichtquelle mit Array-LEDs zum direkten Betrieb am Wechselspannungsnetz und Herstellungsverfahren hierfür
MY164112A (en) * 2010-07-07 2017-11-30 Aft Pharmaceuticals Ltd A combination composition comprising ibuprofen and paracetamol
LT2635269T (lt) * 2010-11-04 2019-09-10 Aft Pharmaceuticals Limited Derinio kompozicija
AU2012253834B2 (en) * 2011-05-06 2016-06-16 Glaxosmithkline Consumer Healthcare (Uk) Ip Limited Sustained release paracetamol formulations
JP6009928B2 (ja) * 2012-12-14 2016-10-19 ダイハツ工業株式会社 車両のサスペンション
KR102373089B1 (ko) * 2017-03-30 2022-03-11 한미약품 주식회사 이부프로펜 및 아세트아미노펜을 포함하는 약제학적 조성물 및 이의 제조방법
AU2018300075B2 (en) 2017-07-10 2024-02-29 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
EP3700509B1 (en) 2017-11-29 2023-11-22 Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi Color stable fixed dose tablet combination of ibuprofen and paracetamol
US11197830B2 (en) * 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
KR20220027194A (ko) 2019-06-27 2022-03-07 글락소스미스클라인 컨슈머 헬스케어 홀딩스 (유에스) 엘엘씨 신규 이부프로펜 및 아세트아미노펜 조성물
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
ZA959469B (en) 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
KR970000231A (ko) * 1995-06-12 1997-01-21 박형미 진통소염제의 의약조성물
JP3982889B2 (ja) 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
JP5630943B2 (ja) 2004-07-07 2014-11-26 エイ・エフ・ティ・ファーマスーティカルズ・リミテッドＡｆｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｉｍｉｔｅｄ 複合剤組成物
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
KR20110112279A (ko) 2008-10-14 2011-10-12 에이에프티 파마슈티칼스 리미티드 의약품 및 치료

Also Published As

Publication number Publication date
AU2008202029A1 (en) 2009-11-26
CY2023026I1 (el) 2024-02-16
LTC1781277I2 (enExample) 2024-07-10
WO2006004449A2 (en) 2006-01-12
MX2007000117A (es) 2007-06-15
US20080200549A1 (en) 2008-08-21
ZA200700896B (en) 2008-07-30
GB2431346B (en) 2010-01-27
GB2431346C (en) 2010-02-17
ES2381794T3 (es) 2012-05-31
EP1781277A2 (en) 2007-05-09
CY2023026I2 (el) 2025-03-28
RU2010147287A (ru) 2012-05-27
DK1781277T3 (da) 2012-05-07
EP1781277A4 (en) 2008-09-03
JP5630943B2 (ja) 2014-11-26
RU2455983C1 (ru) 2012-07-20
CA2570474C (en) 2010-01-05
AU2005260243B2 (en) 2009-10-29
KR101370712B1 (ko) 2014-03-06
LTPA2024501I1 (enExample) 2024-02-12
AU2005260243A1 (en) 2006-01-12
CA2570474A1 (en) 2006-01-12
EP1781277B1 (en) 2012-02-01
WO2006004449A3 (en) 2006-03-02
US20080275125A1 (en) 2008-11-06
RU2007101686A (ru) 2008-08-20
JP2008505889A (ja) 2008-02-28
PT1781277E (pt) 2012-05-07
CN101022789A (zh) 2007-08-22
KR20070034614A (ko) 2007-03-28
GB0700027D0 (en) 2007-02-07
ATE543491T1 (de) 2012-02-15
GB2431346A (en) 2007-04-25
SI1781277T1 (sl) 2012-07-31
US20140073696A1 (en) 2014-03-13
US10532036B2 (en) 2020-01-14
BRPI0512756A (pt) 2008-04-08
US20110275718A1 (en) 2011-11-10
PL1781277T3 (pl) 2012-07-31

Similar Documents

Publication Publication Date Title
CY1117656T1 (el) Επιλογες θεραπειας για τη νοσο του fabry
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
DK1781277T3 (da) Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
IS7431A (is) Samrunaefnasambönd lyfja eða frumudrepandi efna og líffræðilega virkra peptíða
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
CY1107512T1 (el) Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
AR047841A1 (es) Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
CY1124650T1 (el) Φαρμακευτικο παρασκευασμα που περιεχει ινσουλινη σε κρυσταλλικη μορφη καθως και σε διαλυτοποιημενη μορφη
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
CY1122198T1 (el) Ιατρικο προϊον και θεραπεια
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
DK1643999T3 (da) Pyridoxamin til anvendelse ved behandlingen af diabetisk nefropati ved type 2-diabetes
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
SE0203817D0 (sv) New composition
CY1105105T1 (el) Χρηση του διστροντιου αλατος του 2-[ν,ν-δι(καρβοξυμεξυλ) amino]- 3-κυανο-4-καρβοξυμεθυλ-θειοφενο-5-καρβοξυλικου οξεος για τη ληψη φαρμακων που προοριζονται για τη θεραπεια γαστρο-δωδεκαδακτυλικων πονων
CY1108865T1 (el) Υποκατεστημενες 2,5-διαμινομευθυλο-1η-πυρρολες
PT1233786E (pt) Produto contendo pelo menos uma substancia inibidora das no sintases associada a pelo menos uma substancia inibidora das fosfolipases a2 para preparacao de um medicamento